Bioprocessing Technologies in Stem Cell Research:
Challenges and Chances for Commercialization
The Stem Cell Community Day connects researchers from all over the world to discuss recent advances in the stem cells field, with a special focus on controlled cultivation in bioreactors.
Stem cell-based technologies lay the basis for pioneering approaches in regenerative medicine, drug screening, and toxicology testing. Their commercial use requires reliable methods for the large-scale production of stem cells in consistent quality.
At our 1st Stem Cell Community Day we brought together experts from industry and academia, to discuss recent achievements, challenges, and chances in stem cell bioprocessing for research and commercial manufacturing.
Thank you to all participants and all speakers for making the 1st Stem Cell Community Day a great success!
Congratulations to the winners of the poster prize!
Diana Massai, Hannover Medical School, Germany
Insulin precipitation induced by peristaltic pump-based medium circulation impairs culture of human pluripotent stem cells
Caroline Halloin, Hannover Medical School, Germany
Chemically defined large scale human pluripotent stem cell differentiation into cardiomyocytes
Mariana Petronela Hanga, Aston University Birmingham, United Kingdom
A liquid/liquid two phase system as an economic alternative for the large scale expansion of bone marrow-derived human mesenchymal stem/stromal cells (hMSCs)